Literature DB >> 7768779

Plasmid-mediated production of class I (AmpC) beta-lactamase by two Klebsiella pneumoniae isolates from the UK.

P J Jenks, Y M Hu, F Danel, S Mehtar, D M Livermore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7768779     DOI： 10.1093/jac/35.1.235

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  13 in total

Review 1.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  First report of Salmonella isolates with the DHA-1 AmpC beta-lactamase in the United Kingdom.

Authors:  E Liebana; M Batchelor; F A Clifton-Hadley; R H Davies; K L Hopkins; E J Threlfall
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

3.  Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center.

Authors:  P E Coudron; E S Moland; K S Thomson
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

4.  Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.

Authors:  K S Thomson; C C Sanders; E S Moland
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

Review 5.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

6.  Characterization of AmpC-mediated resistance in clinical Salmonella isolates recovered from humans during the period 1992 to 2003 in England and Wales.

Authors:  M Batchelor; K L Hopkins; E J Threlfall; F A Clifton-Hadley; A D Stallwood; R H Davies; E Liebana
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

7.  Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2).

Authors:  M Gazouli; L S Tzouvelekis; E Prinarakis; V Miriagou; E Tzelepi
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

8.  Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen.

Authors:  M G Cormican; S A Marshall; R N Jones
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

9.  Characterization of a novel AmpC-type plasmid-mediated beta-lactamase from an Escherichia coli strain isolated in China.

Authors:  Qian Wang; Jun Cheng; Yan Chen; Ying Ye; Jia-Bin Li; Xue-Jun Zhang
Journal:  Curr Microbiol       Date:  2008-09-10       Impact factor: 2.188

10.  PCR-Based Detection of Extended-Spectrum β-Lactamases (bla CTX-M-1 and bla TEM ) in Escherichia coli, Salmonella spp. and Klebsiella pneumoniae Isolated from Pigs in North Eastern India (Mizoram).

Authors:  H Lalzampuia; T K Dutta; Iadarilin Warjri; Rajesh Chandra
Journal:  Indian J Microbiol       Date:  2013-02-22       Impact factor: 2.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.